OE33 In Vitro Protein Expression Analysis Assay (Western Blot)

CAT#: ITS-1122-YF1876
Target Cell Organism: Human
Target Cell Alternative Name: JROECL33
Target Cell Name: OE33
Assay Type: Gene and Protein Expression Assays
Assay Overview
This assay is to provide OE33-based In Vitro Protein Expression Analysis Assay (Western Blot) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
OE33
Target Cell Organism
Human
Target Cell Background
The cell line OE33, also known as JROECL33, was established from the adenocarcinoma of the lower oesophagus (Barrett's metaplasia) of a 73 year old female patient. The tumour was identified as pathological stage IIA (UICC) and showed poor differentiation.
Target Cell Alternative Name
JROECL33
Related Diseases
Esophageal Adenocarcinoma
Research Area
Oncology
Assay Name
In Vitro Protein Expression Analysis Assay (Western Blot)
Short Description
OE33-cell based In Vitro Protein Expression Analysis Assay (Western Blot)
Assay Description
For protein expression, western blotting and immunoassays have provided high-quality quantitative results. 2D gel electrophoresis
Assay Type
Gene and Protein Expression Assays
Assay Type Details
Following transcription, primary transcript RNA is converted into mature RNA by post-transcriptional modifications. Post-transcriptional modification includes three major steps namely the addition of a 5'cap, addition of a 3'polyadenylation tail and RNA splicing. Stability of RNA has been considered as very important for gene expression and proteins at the post-transcriptional level.
For Research Use Only | Not For Clinical Use
Online Inquiry